Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men

Inik Chang, Shinichiro Fukuhara, Darryn K. Wong, Ankurpreet Gill, Yozo Mitsui, Shahana Majid, Sharanjot Saini, Soichiro Yamamura, Takeshi Chiyomaru, Hiroshi Hirata, Koji Ueno, Sumit Arora, Varahram Shahryari, Guoren Deng, Z. Laura Tabatabai, Kirsten L. Greene, DongMin Shin, Hideki Enokida, Hiroaki Shiina, Norio Nonomura & 2 others Rajvir Dahiya, Yuichiro Tanaka

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The cytochrome P450 1B1 (CYP1B1) enzyme activates xenobiotics to reactive forms as well as convert estra-diol to 4-hydroxy-estradiol that has been shown to play a role in the carcinogenesis process of the kidney in male but not female animals. Prior reports show polymorphic variants of CYP1B1 to alter catalytic activity, and thus, we hypothesize that polymorphisms of the CYP1B1 gene are involved in the malignant transformation of the renal cell in men. The genetic distributions of five CYP1B1 polymorphisms were analyzed by polymerase chain reaction–restriction fragment length polymorphism in 480 normal healthy subjects and 403 sporadic renal cell carcinoma cases. All subjects were Caucasian men. The sites evaluated were codons 48 (C→G, Arg→Gly, rs10012), 119 (G→T, Ala→Ser, rs1056827), 432 (C→G, Leu→Val, rs1056836), 449 (C→T, Asp, rs1056837), and 453 (A→G, Asn→Ser, rs1800440). A trend was demonstrated for the 432 Val/Val (χ2, P=0.06) and 449 T/T (χ2, P=0.1) genotypes to play a protective role against renal cancer. Odds ratio (95% confidence interval) for Val/Val compared to Leu/ Leu at codon 432 was 0.65 (0.44–0.95) and T/T compared to C/C at codon 449 was 0.67 (0.45–0.99). Codons 432 and 449 were observed to be linked (D=0.24), and haplotype involving 432 Val and 449 T was significantly reduced in cancer cases (P=0.04). No association was found, however, when analyzing polymorphic sites with clinical stage of cancer. These results demonstrate polymorphisms of CYP1B1 to be associated with renal carcinogenesis and are of importance in understanding their role in the pathogenesis of renal cell carcinoma.

Original languageEnglish
Pages (from-to)10223-10230
Number of pages8
JournalTumor Biology
Volume35
Issue number10
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Renal Cell Carcinoma
Cytochrome P-450 Enzyme System
Codon
Kidney
Carcinogenesis
Kidney Neoplasms
Xenobiotics
Viperidae
Haplotypes
Estradiol
Neoplasms
Healthy Volunteers
Odds Ratio
Genotype
Confidence Intervals
Genes

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Chang, I., Fukuhara, S., Wong, D. K., Gill, A., Mitsui, Y., Majid, S., ... Tanaka, Y. (2014). Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumor Biology, 35(10), 10223-10230. https://doi.org/10.1007/s13277-014-2292-3
Chang, Inik ; Fukuhara, Shinichiro ; Wong, Darryn K. ; Gill, Ankurpreet ; Mitsui, Yozo ; Majid, Shahana ; Saini, Sharanjot ; Yamamura, Soichiro ; Chiyomaru, Takeshi ; Hirata, Hiroshi ; Ueno, Koji ; Arora, Sumit ; Shahryari, Varahram ; Deng, Guoren ; Laura Tabatabai, Z. ; Greene, Kirsten L. ; Shin, DongMin ; Enokida, Hideki ; Shiina, Hiroaki ; Nonomura, Norio ; Dahiya, Rajvir ; Tanaka, Yuichiro. / Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men. In: Tumor Biology. 2014 ; Vol. 35, No. 10. pp. 10223-10230.
@article{9029616090fa4ea7af6f1968556e19ca,
title = "Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men",
abstract = "The cytochrome P450 1B1 (CYP1B1) enzyme activates xenobiotics to reactive forms as well as convert estra-diol to 4-hydroxy-estradiol that has been shown to play a role in the carcinogenesis process of the kidney in male but not female animals. Prior reports show polymorphic variants of CYP1B1 to alter catalytic activity, and thus, we hypothesize that polymorphisms of the CYP1B1 gene are involved in the malignant transformation of the renal cell in men. The genetic distributions of five CYP1B1 polymorphisms were analyzed by polymerase chain reaction–restriction fragment length polymorphism in 480 normal healthy subjects and 403 sporadic renal cell carcinoma cases. All subjects were Caucasian men. The sites evaluated were codons 48 (C→G, Arg→Gly, rs10012), 119 (G→T, Ala→Ser, rs1056827), 432 (C→G, Leu→Val, rs1056836), 449 (C→T, Asp, rs1056837), and 453 (A→G, Asn→Ser, rs1800440). A trend was demonstrated for the 432 Val/Val (χ2, P=0.06) and 449 T/T (χ2, P=0.1) genotypes to play a protective role against renal cancer. Odds ratio (95{\%} confidence interval) for Val/Val compared to Leu/ Leu at codon 432 was 0.65 (0.44–0.95) and T/T compared to C/C at codon 449 was 0.67 (0.45–0.99). Codons 432 and 449 were observed to be linked (D=0.24), and haplotype involving 432 Val and 449 T was significantly reduced in cancer cases (P=0.04). No association was found, however, when analyzing polymorphic sites with clinical stage of cancer. These results demonstrate polymorphisms of CYP1B1 to be associated with renal carcinogenesis and are of importance in understanding their role in the pathogenesis of renal cell carcinoma.",
author = "Inik Chang and Shinichiro Fukuhara and Wong, {Darryn K.} and Ankurpreet Gill and Yozo Mitsui and Shahana Majid and Sharanjot Saini and Soichiro Yamamura and Takeshi Chiyomaru and Hiroshi Hirata and Koji Ueno and Sumit Arora and Varahram Shahryari and Guoren Deng and {Laura Tabatabai}, Z. and Greene, {Kirsten L.} and DongMin Shin and Hideki Enokida and Hiroaki Shiina and Norio Nonomura and Rajvir Dahiya and Yuichiro Tanaka",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s13277-014-2292-3",
language = "English",
volume = "35",
pages = "10223--10230",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "10",

}

Chang, I, Fukuhara, S, Wong, DK, Gill, A, Mitsui, Y, Majid, S, Saini, S, Yamamura, S, Chiyomaru, T, Hirata, H, Ueno, K, Arora, S, Shahryari, V, Deng, G, Laura Tabatabai, Z, Greene, KL, Shin, D, Enokida, H, Shiina, H, Nonomura, N, Dahiya, R & Tanaka, Y 2014, 'Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men', Tumor Biology, vol. 35, no. 10, pp. 10223-10230. https://doi.org/10.1007/s13277-014-2292-3

Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men. / Chang, Inik; Fukuhara, Shinichiro; Wong, Darryn K.; Gill, Ankurpreet; Mitsui, Yozo; Majid, Shahana; Saini, Sharanjot; Yamamura, Soichiro; Chiyomaru, Takeshi; Hirata, Hiroshi; Ueno, Koji; Arora, Sumit; Shahryari, Varahram; Deng, Guoren; Laura Tabatabai, Z.; Greene, Kirsten L.; Shin, DongMin; Enokida, Hideki; Shiina, Hiroaki; Nonomura, Norio; Dahiya, Rajvir; Tanaka, Yuichiro.

In: Tumor Biology, Vol. 35, No. 10, 01.01.2014, p. 10223-10230.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men

AU - Chang, Inik

AU - Fukuhara, Shinichiro

AU - Wong, Darryn K.

AU - Gill, Ankurpreet

AU - Mitsui, Yozo

AU - Majid, Shahana

AU - Saini, Sharanjot

AU - Yamamura, Soichiro

AU - Chiyomaru, Takeshi

AU - Hirata, Hiroshi

AU - Ueno, Koji

AU - Arora, Sumit

AU - Shahryari, Varahram

AU - Deng, Guoren

AU - Laura Tabatabai, Z.

AU - Greene, Kirsten L.

AU - Shin, DongMin

AU - Enokida, Hideki

AU - Shiina, Hiroaki

AU - Nonomura, Norio

AU - Dahiya, Rajvir

AU - Tanaka, Yuichiro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The cytochrome P450 1B1 (CYP1B1) enzyme activates xenobiotics to reactive forms as well as convert estra-diol to 4-hydroxy-estradiol that has been shown to play a role in the carcinogenesis process of the kidney in male but not female animals. Prior reports show polymorphic variants of CYP1B1 to alter catalytic activity, and thus, we hypothesize that polymorphisms of the CYP1B1 gene are involved in the malignant transformation of the renal cell in men. The genetic distributions of five CYP1B1 polymorphisms were analyzed by polymerase chain reaction–restriction fragment length polymorphism in 480 normal healthy subjects and 403 sporadic renal cell carcinoma cases. All subjects were Caucasian men. The sites evaluated were codons 48 (C→G, Arg→Gly, rs10012), 119 (G→T, Ala→Ser, rs1056827), 432 (C→G, Leu→Val, rs1056836), 449 (C→T, Asp, rs1056837), and 453 (A→G, Asn→Ser, rs1800440). A trend was demonstrated for the 432 Val/Val (χ2, P=0.06) and 449 T/T (χ2, P=0.1) genotypes to play a protective role against renal cancer. Odds ratio (95% confidence interval) for Val/Val compared to Leu/ Leu at codon 432 was 0.65 (0.44–0.95) and T/T compared to C/C at codon 449 was 0.67 (0.45–0.99). Codons 432 and 449 were observed to be linked (D=0.24), and haplotype involving 432 Val and 449 T was significantly reduced in cancer cases (P=0.04). No association was found, however, when analyzing polymorphic sites with clinical stage of cancer. These results demonstrate polymorphisms of CYP1B1 to be associated with renal carcinogenesis and are of importance in understanding their role in the pathogenesis of renal cell carcinoma.

AB - The cytochrome P450 1B1 (CYP1B1) enzyme activates xenobiotics to reactive forms as well as convert estra-diol to 4-hydroxy-estradiol that has been shown to play a role in the carcinogenesis process of the kidney in male but not female animals. Prior reports show polymorphic variants of CYP1B1 to alter catalytic activity, and thus, we hypothesize that polymorphisms of the CYP1B1 gene are involved in the malignant transformation of the renal cell in men. The genetic distributions of five CYP1B1 polymorphisms were analyzed by polymerase chain reaction–restriction fragment length polymorphism in 480 normal healthy subjects and 403 sporadic renal cell carcinoma cases. All subjects were Caucasian men. The sites evaluated were codons 48 (C→G, Arg→Gly, rs10012), 119 (G→T, Ala→Ser, rs1056827), 432 (C→G, Leu→Val, rs1056836), 449 (C→T, Asp, rs1056837), and 453 (A→G, Asn→Ser, rs1800440). A trend was demonstrated for the 432 Val/Val (χ2, P=0.06) and 449 T/T (χ2, P=0.1) genotypes to play a protective role against renal cancer. Odds ratio (95% confidence interval) for Val/Val compared to Leu/ Leu at codon 432 was 0.65 (0.44–0.95) and T/T compared to C/C at codon 449 was 0.67 (0.45–0.99). Codons 432 and 449 were observed to be linked (D=0.24), and haplotype involving 432 Val and 449 T was significantly reduced in cancer cases (P=0.04). No association was found, however, when analyzing polymorphic sites with clinical stage of cancer. These results demonstrate polymorphisms of CYP1B1 to be associated with renal carcinogenesis and are of importance in understanding their role in the pathogenesis of renal cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=84922395225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922395225&partnerID=8YFLogxK

U2 - 10.1007/s13277-014-2292-3

DO - 10.1007/s13277-014-2292-3

M3 - Article

VL - 35

SP - 10223

EP - 10230

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 10

ER -

Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S et al. Cytochrome p450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumor Biology. 2014 Jan 1;35(10):10223-10230. https://doi.org/10.1007/s13277-014-2292-3